Clinical Trial Update: A Study of RC48-ADC Combined With JS001 for Advanced Extramammary Paget Disease of the Scrotum [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating RC48-ADC in combination with JS001 for advanced extramammary Paget's disease of the scrotum is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extramammary Paget Disease

Drugs mentioned

• JS001 (PD-1 inhibitor)
• RC48-ADC (Disitamab Vedotin)

Snippet

Sponsor: Fujian Medical University Union Hospital | Conditions: Paget Disease, Extramammary, Scrotum Disease | Phase 2 | Status: RECRUITING